GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » Ending Cash Position

TrivarX (ASX:TRI) Ending Cash Position : A$0.31 Mil (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is TrivarX Ending Cash Position?

TrivarX's Ending Cash Position for the quarter that ended in Dec. 2023 was A$0.31 Mil.

TrivarX's quarterly Ending Cash Position declined from Dec. 2022 (A$0.32 Mil) to Jun. 2023 (A$0.21 Mil) but then increased from Jun. 2023 (A$0.21 Mil) to Dec. 2023 (A$0.31 Mil).

TrivarX's annual Ending Cash Position declined from Jun. 2021 (A$2.31 Mil) to Jun. 2022 (A$1.03 Mil) and declined from Jun. 2022 (A$1.03 Mil) to Jun. 2023 (A$0.21 Mil).


TrivarX Ending Cash Position Historical Data

The historical data trend for TrivarX's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Ending Cash Position Chart

TrivarX Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 0.81 2.31 1.03 0.21

TrivarX Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 1.03 0.32 0.21 0.31

TrivarX Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

TrivarX's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.033+-0.819
=0.21

TrivarX's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.215+0.096
=0.31


TrivarX Ending Cash Position Related Terms

Thank you for viewing the detailed overview of TrivarX's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX (ASX:TRI) Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.